Clinical Results

To objectively monitor pre and post response to the Arthritis Treatment Centers treatments, patients are requested to complete the WOMAC (lower extremities) or DASH (upper extremities) questionnaires, which probe for clinically important, patient-relevant symptoms in the areas of pain, stiffness and physical function.

The WOMAC instrument is one of two recognized by the FDA for use in all arthritis clinical research studies. Arthritis Treatment Centers has made WOMAC assessments a standard practice in the centers' daily operations.

After the baseline arthritis index is created, patient-specific treatment goals are defined. This helps the patient visualize their progress and allows treatment centers professionals to standardize patient progress reports to referring doctors. The WOMAC reports also give our clinicians valuable feedback and are a key to refining the ongoing longer-term treatment protocols and exercise programs.

From 385 patients who completed the basic course of 10 treatments sessions, the documented results in the Toronto clinic were as follows:

• 80% of patients recorded an average decrease in pain by 42%
• 86% of patients had an improvement in function of 40%
• 64% of patients recorded an average decrease in stiffness by 49%

Results from baseline readings are statistically significant 99.9% of the time with a confidence level of 99%.

The proprietary software programs, developed by HealthSonix specifically for Clinic and Patient Management, allow for in depth analysis of all clinical results: for example, the data base shows that Patients' age ranges from 13 to 101, and that the average age of the patients is 68.4 years.

The data base also allows for probing of results by 'condition', as shown in these charts:

Results for patients currently on medications and/or supplements (note: the resultant improvements are over and above the patients' base lines measured while they were on medications and supplements and prior to their first treatment).